Officially Idera is about to acquire Embarcadero this week after final agreements are made. Idera press release provides you with some additional information concerning the purchase. At this moment no one really knows what this means for the Rad Studio product as well the other database packages that Embarcadero sells nor what will happen with the company name.
At this point the Embarcadero staff members are pretty happy and developers will have to wait until something is provided by Idera. Usually in purchases older products that have no relevance are stopped and particular development sites are dropped to condense the groups. and finally Idera managers take over after the internal review of what is happening.
Some things that can changed in the next year or so:
- EDN (Embarcadero Developers Network) which provides the product updates needs a serious remake.
- Product pricing will that remain stable, decrease or increase ?
- With over 3 million world wide developers what will happen with the VCL version for Window development ? Will Firemonkey become the dominate software tool ?
- The database powerstudio software tools will that be merged with the Idera SQL product lines ?
- HTML 5 Builder will that be discontinued, it seems nothing has been done with the product since XE5
- What will happen with the Embarcadero name, will that disappear or be a jointed name for a period of time.
- When will the company chart of board members be released ?
These are just some of the questions that are being asked and there are numerous others so stay tuned.
- Are Vasectomies Actually Reversible? Doctors Explain.by LaunchPad Developer on December 20, 2024 at 4:50 pm
Dr. Alexander Epelbaum explains vasectomies and vasectomy reversals in this Men’s Health article Read the full article. The post Are Vasectomies Actually Reversible? Doctors Explain. appeared first on Advanced Urology Centers of New York.
- First physicians to implant BioProtect Balloon in US describe benefits of the spacerby LaunchPad Developer on November 22, 2024 at 3:09 am
In this interview, Shawn Zimberg, MD, and Dean Laganosky, MD, discuss the BioProtect Balloon Transplant System, a rectal spacer that received FDA clearance in August 2023 for use during prostate cancer radiation.1 Zimberg–a radiation oncologist and medical director at Advanced Radiation Centers (ARC) of New York, a division of Integrated Medical Professionals (IMP)–performed the first The post First physicians to implant BioProtect Balloon in US describe benefits of the spacer appeared first on Advanced Urology Centers of New York.